Ronald Ross Watson
Immune Dysfunction and Immunotherapy in Heart Disease
Buch
Current heart failure therapeutics affects symptoms without appreciably reducing the mortality rate of 50% in five years -- suggesting a failure in treating the underlying mechanism. This book proposes a new mechanism for heart failure; immune mediated cardiac remodelling for cardiac dysfunction.The outstanding editor team of two internationally recognized immunologists -- Ronald Watson, who has studied heart disease in immune dysfunction for a decade and has a patent for an immunotherapy of heart disease by immune regulation, and Douglas Larson, whose experience in cardiac transplantation immunology has provided the foundation for research i…
Mehr
Beschreibung
Current heart failure therapeutics affects symptoms without appreciably reducing the mortality rate of 50% in five years -- suggesting a failure in treating the underlying mechanism. This book proposes a new mechanism for heart failure; immune mediated cardiac remodelling for cardiac dysfunction.The outstanding editor team of two internationally recognized immunologists -- Ronald Watson, who has studied heart disease in immune dysfunction for a decade and has a patent for an immunotherapy of heart disease by immune regulation, and Douglas Larson, whose experience in cardiac transplantation immunology has provided the foundation for research into novel therapeutics for heart failure and hypertension - makes Immune Dysfunction and Immunotherapy in Heart Disease the definitive reference to the state of the science in this area.The four parts of the book address:* Immune Dysfunction Leading to Heart Disease: Induction by Physiological Changes* Immune Dysfunction Promoting CVD: Induction by Transplantation Drugs* Immune Dysfunction Leading to Heart Dysfunction: Induction or Prevention by Cardiotherapeutic Drugs* Immune Dysfunction Leading to Heart Disease: Induction by PathogensBoth researchers and practitioners will find this authoritative volume an excellent source of information on novel immune targeted therapeutics.
CHF 221.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V112:
Lieferbar in ca. 10-20 Arbeitstagen
Produktdetails
Weitere Autoren: Larson, Douglas
- ISBN: 978-1-4051-5568-7
- EAN: 9781405155687
- Produktnummer: 3085037
- Verlag: Wiley
- Sprache: Englisch
- Erscheinungsjahr: 2007
- Seitenangabe: 328 S.
- Masse: H26.5 cm x B18.9 cm x D2.0 cm 900 g
- Gewicht: 900
Über den Autor
Dr. Larson and Dr. Watson have worked together researching the role of immune and cytokine dysfunction in heart disease for 8 years. They have been and currently are funded to do such research by grants from the U.S. National Institute of Heart, Lung and Blood, the American Heart Foundation, companies and private foundations. Dr. Watson has edited 62 scientific books, including several dealing with heart disease and conditions such as aging and AIDS that promote immune dysfunction as well as heart disease. Dr. Larson directs the Center's organ perfusion program as well as its Master degree in pharmacology and toxicology for perfusion students.____________________________________________________________________Ronald Ross Watson Ph.D.Professor Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health and the Sarver Heart Center in the School of Medicine, University of Arizona, P. O. Box 245155, 1501 N. Campbell Avenue, Tucson, AZ 85749.(520) 626 2850, Fax (520) 626 6093 rwatson@u.arizona.edu____________________________________________________________________Douglas F. Larson Ph.D.Professor Surgery and the Sarver Heart Center in the School of Medicine, University of Arizona, P. O. Box 245066, 1501 N. Campbell Avenue, Tucson, AZ 85749. (520) 626 6494 dflarson@email.arizona.edu
100 weitere Werke von Ronald Ross Watson:
Ebook (EPUB Format)
CHF 145.75
Ebook (EPUB Format)
CHF 199.95
Ebook (EPUB Format)
CHF 309.60
Ebook (EPUB Format)
CHF 238.65
Bewertungen
0 von 0 Bewertungen
Anmelden
Keine Bewertungen gefunden. Seien Sie der Erste und teilen Sie Ihre Erkenntnisse mit anderen.